GlaxoSmithKline has exited the CDS platform operator, which has been purchased by patient care software provider Amalgam Rx for an undisclosed sum.
Digital healthcare product supplier Amalgam Rx has bought Avhana Health, a US-based clinical decision support (CDS) system producer backed by pharmaceutical firm GlaxoSmithKline, for an undisclosed amount.
Founded in 2014, Avhana provides software that leverages logged electronic health records to help medical professionals with clinical decision making. The product is used in 32 US states by a customer base of thousands of healthcare providers.
Amalgam Rx was founded in 2016 and provides patient support schemes, digital therapeutics and products combining…
